Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population

  title={Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population},
  author={Erik Osterman and Bengt Glimelius},
  journal={Diseases of the Colon \& Rectum},
BACKGROUND: Developments in the quality of care of patients with colon cancer have improved surgical outcome and thus the need for adjuvant chemotherapy. OBJECTIVE: To investigate the recurrence rate in a large population-based cohort after modern staging, surgery, and pathology have been implemented. DESIGN: This was a retrospective registry study. SETTINGS: Data from patients included in the Swedish Colorectal Cancer Registry covering 99% of all cases and undergoing surgery for colon cancer… 

Disease recurrence after colorectal cancer surgery in the modern era: a population-based study

Recurrence rates in recently treated patients with CRC were lower than reported in the literature and the metastatic pattern and recurrence risks varied between anatomical sublocations.

Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial

The high proportion of patients who received potentially curative treatment, linked to a 5-year overall survival rate of 58.6 per cent, indicates that it is possible to achieve good results in recurrent colorectal cancer following multidisciplinary assessment.

Postoperative CEA and Other Non-traditional Risk Factors for Colon Cancer Recurrence: Findings from Swedish Population-Based Data

Postoperative CEA was independently predictive of disease-free and overall survival, after controlling for age, sex, treatment, T and N stage, BRAF mutation status, and mismatch repair status; some of the classic risk factors for recurrence, such as T stage, inadequate LN sampling, and vascular invasion, did not statistically correlate with recurrence.

Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer

While recurrence rates were lower with stage I and II disease, the high rate of metastatic disease resection and excellent post-resection outcomes help to justify routine surveillance in these patients.

Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study

Using primarily abstracted recurrence data from a random sample of patients treated for CRC at CoC accredited centers across the United States, an individualized CRC recurrence risk assessment tool is created that can be used by physicians and patients in shared decision making to guide management discussions.

Predictive factors for distant recurrence of colorectal cancer in patients after curative resection for stage I–III colorectal cancer in Australia

Among patients with distant recurrence, treatment with surgery conferred the best survival, with patients < 50 years of age having the best overall 5-year survival.

Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort

Investigation of parameters commonly collected in clinical management added information about recurrence risk against a background of routine clinicopathological parameters as defined by the NCCN correlated with recurrence.

Risk Factors of Colorectal Cancer Recurrence After Curative Resection Surgery: A Systematic Review and Meta-Analysis

The elevation of post-operative CEA serum was assumed as the main factor in this study; however, most of the studied parameters were statistically significant.

Factors associated with colon cancer early, intermediate and late recurrence after surgery for stage I-III: A 5-year prospective study.

These risk factors show good predictive ability of early, intermediate and late recurrence, confirming factors established by guidelines and adding some others, and could serve to provide more appropriate and accurate treatment and follow-up tailored to patient characteristics.

Early postoperative recurrences for colon cancer: Results from a Pakistani rural cohort




Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

A meta-analysis of randomized controlled studies and observational studies published after 1 January 2005 found that the presented five-year disease-free survival (DFS) for stage II and III colon cancer patients is likely an under-estimation of what is achieved at high-quality centers today.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

  • S. GillC. Loprinzi R. Goldberg
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2004
Patients with high-risk resected colon cancer obtain benefit from FU-based therapy across subsets of age, sex, location, T stage, nodal status, and grade, which may improve patients' and physicians' understanding of the potential benefits of adjuvant therapy.

Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients

Primary tumour location is an important prognostic factor in locoregional colon cancer with an effect that varies by stage, and RsCC is associated with lower all-cause mortality in stage II, and higher all- cause mortality in stages III.

Improved survival of colorectal cancer in Denmark during 2001–2012 – The efforts of several national initiatives

The Danish efforts to improve outcome of cancer have succeeded with improved outcomes in patients with colorectal cancer, with focus on comorbidity, stage, and perioperative treatment.

Nomogram for predicting recurrence in stage II colorectal cancer

Sex, carcinoembryonic antigen, tumor location, tumor depth, lymphatic invasion, venous invasion and number of lymph nodes studied were significantly associated with recurrence and a nomogram for five-year freedom from recurrence was created.

Individualized prediction of colon cancer recurrence using a nomogram.

  • M. WeiserR. Landmann W. Wong
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
Using common clinicopathologic factors, the recurrence nomogram is better able to account for tumor and patient heterogeneity, thereby providing a more individualized outcome prognostication than that afforded by the AJCC categoric system.

Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007

Differences in stage at diagnosis partly explain international differences in colorectal cancer survival, with a more adverse stage distribution contributing to comparatively low survival in Denmark.

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

This ESMO guideline is recommended to be used as the basis for treatment and management decisions, delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations.

Improved survival in cancer of the colon and rectum in Sweden.